|
Sign In to gain access to subscriptions and/or personal tools.
|
Impulsivity: a discussion of clinical and experimental findings
John Evenden
Preclinical Research and Development, Astra Arcus, S15185, Sodertaije; Department of Neuroscience, Pharmacology, Biomedical Centre, Uppsala University, Uppsala, Sweden.
Impulsivity can often be an important clinical problem in psychiatry and neurology. In psychiatry, the manifestation of impulsive behaviour in syndromes such as personality disorders, attention deficit hyperactivity disorder and in substance abuse may be different, and this has led to conflicting definitions. There has also been a tendency to concentrate on the nature of the behavioural manifestation (problems with the law, aggression, drug use, behavioural problems in school) rather than shared psychological processes, and to ignore the fact that impulsivity can also have positive aspects. In a normal population, the personality trait of impulsivity has been analysed using personality inventory questionnaires. Analysis of these data lead to the suggestion that impulsivity as commonly defined and understood may be made up of several independent factors, which may have separate biological bases. These self-rating questionnaires have been complemented by objective tests that are now often computerized, and which have been used in man (e.g. with criminal offenders, children, or patients who have undergone brain surgery). Some of these tests, such as the differential reinforcement of low rates procedure or the delay of reinforcement procedure, have also been used to study impulsivity in animals. Analysis of the behavioural principles of these tests suggests that they too may reflect different aspects of impulsivity. Many different biological systems have been proposed to contribute to the neurobiological basis of impulsivity. The serotonergic neurotransmitter system has recently received the most attention, with evidence of its involvement coming from animal studies as well as from studies in psychiatric patients. The frontal lobes have been proposed to play an important role in regulating impulsivity, although it unclear how specific this is. None of this biological knowledge has yet led to reliable pharmacotherapy for excessive impulsivity and, as yet, there is little understanding of the mechanisms by which those drugs, which have been found empirically to have some efficacy (e.g. the psychomotor stimulants in attention deficit hyperactivity disorder), exert their therapeutic effect. By bringing together knowledge from different areas of research it is hoped that a cross fertilization will be achieved, which will lead to a sharpening of concepts, an improvement in methodology and the stimulation of biological studies.
Key Words: impulsivity • man • personality • psychiatric patients • rats • serotonin
Journal of Psychopharmacology, Vol. 13, No. 2,
180-192 (1999)
DOI: 10.1177/026988119901300211
 CiteULike  Complore  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter What's this?
This article has been cited by other articles:
|
|
|
|
 
A. B. Long, C. M. Kuhn, and M. L. Platt
Serotonin shapes risky decision making in monkeys
Soc Cogn Affect Neurosci,
December 1, 2009;
4(4):
346 - 356.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Temel, L. J. Boothman, A. Blokland, P. J. Magill, H. W. M. Steinbusch, V. Visser-Vandewalle, and T. Sharp
Inhibition of 5-HT neuron activity and induction of depressive-like behavior by high-frequency stimulation of the subthalamic nucleus
PNAS,
October 23, 2007;
104(43):
17087 - 17092.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. R. Markus and L. M. Jonkman
Attention switching after dietary brain 5-HT challenge in high impulsive subjects
J Psychopharmacol,
September 1, 2007;
21(7):
700 - 708.
[Abstract]
[PDF]
|
|
|
|
|
|
|
S. L. Lambourne, T. Humby, A. R. Isles, P. C. Emson, M. G. Spillantini, and L. S. Wilkinson
Impairments in impulse control in mice transgenic for the human FTDP-17 tauV337M mutation are exacerbated by age
Hum. Mol. Genet.,
July 15, 2007;
16(14):
1708 - 1719.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. Turle-Lorenzo, B. Maurin, C. Puma, C. Chezaubernard, P. Morain, C. Baunez, A. Nieoullon, and M. Amalric
The Dopamine Agonist Piribedil with L-DOPA Improves Attentional Dysfunction: Relevance for Parkinson's Disease
J. Pharmacol. Exp. Ther.,
November 1, 2006;
319(2):
914 - 923.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. C. Talpos, L. S. Wilkinson, and T. W. Robbins
A comparison of multiple 5-HT receptors in two tasks measuring impulsivity
J Psychopharmacol,
January 1, 2006;
20(1):
47 - 58.
[Abstract]
[PDF]
|
|
|
|
|
|
|
A. C. Swann, D. M. Dougherty, P. J. Pazzaglia, M. Pham, J. L. Steinberg, and F. G. Moeller
Increased Impulsivity Associated With Severity of Suicide Attempt History in Patients With Bipolar Disorder
Am J Psychiatry,
September 1, 2005;
162(9):
1680 - 1687.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Tritt, C. Nickel, C. Lahmann, P. K. Leiberich, W. K. Rother, T. H. Loew, and M. K. Nickel
Lamotrigine treatment of aggression in female borderline-patients: a randomized, double-blind, placebo-controlled study
J Psychopharmacol,
May 1, 2005;
19(3):
287 - 291.
[Abstract]
[PDF]
|
|
|
|
|
|
|
A. R. Isles, T. Humby, E. Walters, and L. S. Wilkinson
Common Genetic Effects on Variation in Impulsivity and Activity in Mice
J. Neurosci.,
July 28, 2004;
24(30):
6733 - 6740.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Blokland, W. Honig, and J. Jolles
Long-term consequences of repeated pentobarbital anaesthesia on choice reaction time performance in ageing rats
Br. J. Anaesth.,
November 1, 2001;
87(5):
781 - 783.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Bechara, D. Tranel, and H. Damasio
Characterization of the decision-making deficit of patients with ventromedial prefrontal cortex lesions
Brain,
November 1, 2000;
123(11):
2189 - 2202.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
